Clinical trials

  • Etrinabdione for Peripheral arterial disease
  • Clinical trial in Locally advanced or metastatic melanoma
  • SOTAGLIFLOZIN for Type 1 diabetes mellitus|Chronic kidney disease (CKD) with albuminuria
  • CARBOPLATIN for Testicular seminoma (Stage IIA/B)
  • AVB-101 for Frontotemporal dementia with progranulin (GRN) mutations
  • amivantamab for Advanced non-small cell lung cancer
  • Ifinatamab deruxtecan for Endometrial cancer | Head and neck squamous cell carcinoma | Pancreatic ductal adenocarcinoma | Colorectal cancer | Hepatocellular carcinoma | Esophageal adenocarcinoma | Gastroesophageal junction adenocarcinoma | Gastric adenocarcinoma | Urothelial carcinoma | Ovarian cancer | Cervical cancer | Biliary tract cancer | Breast cancer (HER2-low) | Breast cancer (HER2 IHC 0) | Cutaneous melanoma
  • CERALASERTIB for Advanced or metastatic non-small cell lung cancer | Non-small cell lung cancer
  • ROSUVASTATIN for Cardiovascular disease
  • 4-((3-((5,6-DIHYDRO-2-(TRIFLUOROMETHYL)(1,2,4)TRIAZOLO(1,5-A)PYRAZIN-7(8H)-YL)CARBONYL)-4-FLUOROPHENYL)METHYL)-1(2H)-PHTHALAZINONE for Metastatic castration-resistant prostate cancer
  • VENLAFAXINE HYDROCHLORIDE for Depressive disorder (in remission)
  • BELIMUMAB for Systemic sclerosis-associated interstitial lung disease (SSc-ILD) | Connective tissue disease-associated interstitial lung disease (CTD-ILD)